Is Entrada Therapeutics, Inc. (TRDA) a Buy, Sell, or Hold?
NASDAQ : TRDA
Entrada Therapeutics, Inc. — Competitors
$7.67 USD
$0.63 (8.95%)
- Volume
- 260.81K
- Average Volume
- 406.57K
- Market Capitalization
- $297.75M
- P/E Ratio
- -1.93
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $16.45
- Year Low
- $5.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.89
TRDA vs. The Competition
| Properties | TRDA | ACHV | ALLO | ARCT |
|---|---|---|---|---|
| Market Cap | $297.75M | $686.79M | $714.47M | $216.02M |
| Shares Outstanding | $38.82M | $102.66M | $345.16M | $28.42M |
| P/E Ratio | -1.93 | -4.32 | -3.09 | -2.28 |
| EPS | -3.93 | -1.22 | -0.5 | -3.28 |
| Day Low | 7.03 | 6.51 | 2.05 | 7.5 |
| Day High | 7.68 | 6.77 | 2.145 | 7.85 |
| Year Low | 5.02 | 2.46 | 0.99 | 5.5 |
| Year High | 16.45 | 7.11 | 4.46 | 24.17 |
| Average Price 50 | 6.8403 | 6.0062 | 1.9554 | 6.764 |
| Average Price 200 | 9.66923 | 4.8687 | 1.88965 | 7.4027 |
| Volume | 260.81K | 1.41M | 4.37M | 422.09K |
| Average Volume | - | - | - | - |